Mostra el registre parcial de l'element

dc.contributor.authorAlbert Gasco, Hector
dc.contributor.authorRos, Francisco
dc.contributor.authorCastillo-Gómez, Esther
dc.contributor.authorOlucha-Bordonau, Francisco E
dc.date.accessioned2020-11-24T11:04:50Z
dc.date.available2020-11-24T11:04:50Z
dc.date.issued2020-06-23
dc.identifier.citationAlbert-Gascó, H.; Ros-Bernal, F.; Castillo-Gómez, E.; Olucha-Bordonau, F.E. MAP/ERK Signaling in Developing Cognitive and Emotional Function and Its Effect on Pathological and Neurodegenerative Processes. Int. J. Mol. Sci. 2020, 21, 4471.ca_CA
dc.identifier.issn1422-0067
dc.identifier.urihttp://hdl.handle.net/10234/190455
dc.description.abstractThe signaling pathway of the microtubule-associated protein kinase or extracellular regulated kinase (MAPK/ERK) is a common mechanism of extracellular information transduction from extracellular stimuli to the intracellular space. The transduction of information leads to changes in the ongoing metabolic pathways and the modification of gene expression patterns. In the central nervous system, ERK is expressed ubiquitously, both temporally and spatially. As for the temporal ubiquity, this signaling system participates in three key moments: (i) Embryonic development; (ii) the early postnatal period; and (iii) adulthood. During embryonic development, the system is partly responsible for the patterning of segmentation in the encephalic vesicle through the FGF8-ERK pathway. In addition, during this period, ERK directs neurogenesis migration and the final fate of neural progenitors. During the early postnatal period, ERK participates in the maturation process of dendritic trees and synaptogenesis. During adulthood, ERK participates in social and emotional behavior and memory processes, including long-term potentiation. Alterations in mechanisms related to ERK are associated with different pathological outcomes. Genetic alterations in any component of the ERK pathway result in pathologies associated with neural crest derivatives and mental dysfunctions associated with autism spectrum disorders. The MAP-ERK pathway is a key element of the neuroinflammatory pathway triggered by glial cells during the development of neurodegenerative diseases, such as Parkinson’s and Alzheimer’s disease, Huntington’s disease, and amyotrophic lateral sclerosis, as well as prionic diseases. The process triggered by MAPK/ERK activation depends on the stage of development (mature or senescence), the type of cellular element in which the pathway is activated, and the anatomic neural structure. However, extensive gaps exist with regards to the targets of the phosphorylated ERK in many of these processes.ca_CA
dc.format.extent30 p.ca_CA
dc.format.mimetypeapplication/pdfca_CA
dc.language.isoengca_CA
dc.publisherMDPIca_CA
dc.relation.isPartOfInt. J. Mol. Sci. 2020, 21, 4471ca_CA
dc.rights© 2020 by the authors. Licensee MDPI, Basel, Switzerlandca_CA
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-sa/4.0/*
dc.subjectlearning; memoryca_CA
dc.subjecthippocampusca_CA
dc.subjectseptumca_CA
dc.subjectlong term potentiationca_CA
dc.subjectlong term depressionca_CA
dc.subjectreceptorca_CA
dc.subjectsynapseca_CA
dc.titleMAP/ERK Signaling in Developing Cognitive and Emotional Function and Its Effect on Pathological and Neurodegenerative Processesca_CA
dc.typeinfo:eu-repo/semantics/articleca_CA
dc.identifier.doihttps://doi.org/10.3390/ijms21124471
dc.relation.projectIDFundación Alicia Koplowitz, Spain, grant number 19I436 ; RTI2018-095698-B-I00 ; GV/2019/088(E.C.-G) ; UJI-B2019-54 (F.E.O.-B.) ; UJI-A2017-17 (F.R.-B.);ca_CA
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca_CA
dc.relation.publisherVersionhttps://www.mdpi.com/1422-0067/21/12/4471ca_CA
dc.type.versioninfo:eu-repo/semantics/publishedVersionca_CA


Fitxers en aquest element

Thumbnail
Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

© 2020 by the authors. Licensee MDPI, Basel, Switzerland
Except where otherwise noted, this item's license is described as © 2020 by the authors. Licensee MDPI, Basel, Switzerland